Atlas Trials

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Clinical trial NCT06021756 · UNKNOWN

Trial details

NCT number
NCT06021756
Sponsor
University of Arizona
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Levodopa-Induced DyskinesiaParkinson's Disease
Start date
2019-07-28
Primary completion
2022-08-25
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.